发明名称 PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES OF THE ORAL CAVITY
摘要 <p>A water-soluble or water-dispersible particulate pharmaceutical composition comprises, per one part by weight of at least one glycyrrhetinic acid derivative selected from the group consisting of glycyrrhetinic acid hemiesters and the salts thereof and the esters of glycyrrhetinic acid and of 3-0-acyl derivatives of glycyrrhetinic acid, 10 to 100 parts by weight of at least one compound selected from the group consisting of lactose and sorbitol, 10 to 50 parts by weight of at least one buffer selected from the group consisting of sodium citrate, potassium citrate, sodium tartrate, potassium tartrate, sodium malate and potassium malate and 0.1 to 10 parts by weight of disodium edetate. The composition of the invention is intended to be dissolved in water to produce a mouthwash to be used in the treatment of ulceration and inflammation of the oral cavity.</p>
申请公布号 CA1171784(A) 申请公布日期 1984.07.31
申请号 CA19820395671 申请日期 1982.02.05
申请人 BIOREX LABORATORIES LIMITED 发明人 TURNER, JOHN C.;BAXENDALE, LILY
分类号 A61K31/19;A61K;A61K6/00;A61K8/63;A61K9/08;A61K9/14;A61K31/045;A61K31/047;A61K31/195;A61K31/215;A61K31/22;A61K31/56;A61K31/70;A61K47/12;A61K47/26;A61P1/04;A61P29/00;A61Q11/00;(IPC1-7):A61K7/16;A61K7/24 主分类号 A61K31/19
代理机构 代理人
主权项
地址